Q1 2025 · 13F-HR
Patient Square Capital LPholdings as filed
Filed 2025-05-14 · accession 0000950123-25-005195
$241.7M
Reported value
19
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G76279101 | ROIV | ROIVANT SCIENCES LTD. | $125.9M | 52.1% | 12,480,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $25.2M | 10.4% | 330,250 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $22.5M | 9.29% | 1,522,452 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS, INC. | $8.0M | 3.32% | 1,481,977 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX, INC. | $6.7M | 2.79% | 920,199 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS, INC. | $6.7M | 2.75% | 878,897 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS, INC. | $5.3M | 2.20% | 447,296 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS, INC. | $5.2M | 2.17% | 116,362 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS, INC. | $5.0M | 2.07% | 253,838 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HOLDING CORPORATION | $5.0M | 2.05% | 154,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE, INC. | $4.1M | 1.70% | 83,000 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS, INC. | $4.1M | 1.69% | 139,732 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS, INC. | $3.9M | 1.61% | 142,201 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N. V. | $3.9M | 1.59% | 245,496 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS, INC. | $3.5M | 1.43% | 2,368,186 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORPORATION | $3.4M | 1.41% | 38,500 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS, INC. | $1.7M | 0.68% | 232,781 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS, INC. | $1.3M | 0.55% | 18,600 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC. | $406,112 | 0.17% | 257,033 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.